Overview / Abstract: |
Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression is fundamental to optimizing management of patients with MS. Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies. |
Expiration |
Jun 22, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.00 AMA PRA Category 1 CreditTM 1.00 ANCC Contact Hour |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Matthew K. Schindler, MD, PhD Edward J. Fox, MD, PhD |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from Genentech, a member of the Roche Group, and Novartis. |
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Multiple sclerosis, DMT, disease modifying, nontraumatic neurologic, early diagnosis, disease progression, inflammatory neurologic, MS CME Free CE CME |